ev3 Hightlights Foxhollow Merger for Endovascular Businesses
October 24, 2007 – ev3 Inc. highlighted at TCT 2007 its merger with FoxHollow Technologies, Inc., which created an organization that possesses one of the largest U.S. distribution footprints in endovascular devices with combined technologies for the advancement of the treatment of peripheral and neurovascular disease.
FoxHollow has become a division of the umbrella company ev3. The combined product portfolio includes a broad spectrum of products to treat vascular disease in both the peripheral and neurovascular markets, including atherectomy and thrombectomy, PTA balloons, stents, embolic protection devices, infusion catheters/wires, embolic coils and liquid embolics.
For more information: www.ev3.net and www.foxhollowtech.com